Vaccine manufacturers and health experts have raised alarm after a U.S. immunization advisory panel voted to end its long-held recommendation that all newborns receive the hepatitis B vaccine at birth. The CDC’s Advisory Committee on Immunization Practices (ACIP) now advises that only infants born to hepatitis B-positive mothers get the immediate dose, while others should